BRPI0518676A2 - composiÇço, uso da mesma, e, mÉtodos de fabricar uma composiÇço e de tratar uma infecÇço microbiana - Google Patents

composiÇço, uso da mesma, e, mÉtodos de fabricar uma composiÇço e de tratar uma infecÇço microbiana

Info

Publication number
BRPI0518676A2
BRPI0518676A2 BRPI0518676-5A BRPI0518676A BRPI0518676A2 BR PI0518676 A2 BRPI0518676 A2 BR PI0518676A2 BR PI0518676 A BRPI0518676 A BR PI0518676A BR PI0518676 A2 BRPI0518676 A2 BR PI0518676A2
Authority
BR
Brazil
Prior art keywords
composition
treating
methods
making
microbial infection
Prior art date
Application number
BRPI0518676-5A
Other languages
English (en)
Inventor
Thomas Hedner
Jan Faergemann
Original Assignee
Ambria Dermatology Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36498274&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0518676(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE0402890A external-priority patent/SE528780C2/sv
Application filed by Ambria Dermatology Ab filed Critical Ambria Dermatology Ab
Publication of BRPI0518676A2 publication Critical patent/BRPI0518676A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02Acyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSIÇçO, USO DA MESMA, E, MÉTODOS DE FABRICAR UMA COMPOSIÇçO E DE TRATAR UMA INFECÇçO MICROBIANA. A presente invenção se refere a uma composição que compreende pelo menos 3 diferentes dióis, segundo os quais ditos dióis têm a estrutura geral (CH~ 2~)nH~ 2~O~ 2~, segundo o qual n é o número de CH~ 2~ e estando entre 3 a 10, em uma quantidade total de 0,1 a cerca de 50% (volume/volume), um método de produzir a composição e seu uso, tal como em terapia. A composição pode ser uma composição farmacêutica, cosmética, antimicrobiana ou conservante. A composição é útil em inativar microorganismos ou evitar seus crescimentos.
BRPI0518676-5A 2004-11-29 2005-11-29 composiÇço, uso da mesma, e, mÉtodos de fabricar uma composiÇço e de tratar uma infecÇço microbiana BRPI0518676A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63114804P 2004-11-29 2004-11-29
SE0402890A SE528780C2 (sv) 2004-11-29 2004-11-29 Antimikrobiell beredning omfattande 3 eller 4 dioler och en metod för att framställa den
PCT/SE2005/001787 WO2006057616A1 (en) 2004-11-29 2005-11-29 A composition comprising at least 3 different diols

Publications (1)

Publication Number Publication Date
BRPI0518676A2 true BRPI0518676A2 (pt) 2008-12-02

Family

ID=36498274

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518676-5A BRPI0518676A2 (pt) 2004-11-29 2005-11-29 composiÇço, uso da mesma, e, mÉtodos de fabricar uma composiÇço e de tratar uma infecÇço microbiana

Country Status (9)

Country Link
US (1) US9757596B2 (pt)
EP (1) EP1827433B2 (pt)
JP (1) JP5179879B2 (pt)
KR (1) KR20070093079A (pt)
AU (1) AU2005310072B2 (pt)
BR (1) BRPI0518676A2 (pt)
CA (1) CA2586815A1 (pt)
RU (1) RU2389481C2 (pt)
WO (1) WO2006057616A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4621897B2 (ja) 2007-08-31 2011-01-26 独立行政法人産業技術総合研究所 固体メモリ
SE533425C2 (sv) * 2008-07-07 2010-09-21 Ambria Dermatology Ab Antimikrobiell sammansättning
US9533479B2 (en) * 2008-09-18 2017-01-03 Medline Industries, Inc. Absorbent articles having antimicrobial properties and methods of manufacturing the same
KR101381903B1 (ko) * 2011-03-10 2014-04-10 주식회사 엘지생활건강 3-부톡시-1,2-프로판다이올을 함유하는 항균 또는 보존용 조성물
US8853189B2 (en) 2012-05-31 2014-10-07 Prima Innovations, Llc Antispasmodic 1,2-Diols and 1,2,3-triols
WO2018157936A1 (en) * 2017-03-02 2018-09-07 Essity Hygiene And Health Aktiebolag Wipe with skin beneficial effect
EP3473097A1 (en) * 2017-10-18 2019-04-24 SCHÜLKE & MAYR GmbH Liquid concentrate for preservation
EP4125791B1 (en) 2020-03-31 2024-10-30 Minasolve SAS Homogeneous liquid composition comprising 1,2-octanediol and use thereof
EP4164383A1 (en) * 2020-06-12 2023-04-19 DSM IP Assets B.V. Novel use
WO2022008088A1 (en) * 2020-07-09 2022-01-13 Symrise Ag Compositions with virucidal and/or antiviral activity
WO2022122135A1 (en) * 2020-12-09 2022-06-16 Symrise Ag Compositions comprising (bio)-alkanediols with antimicrobials for product protection
WO2022122138A1 (en) * 2020-12-09 2022-06-16 Symrise Ag Multifunctional compound mixtures comprising multiple (bio)-alkanediols
WO2022122133A1 (en) * 2020-12-09 2022-06-16 Symrise Ag Compositions comprising uv-filters and one or more (bio)-alkanediols
WO2022122140A1 (en) * 2020-12-09 2022-06-16 Symrise Ag Compositions comprising one or more (bio)-alkanediols with active ingredients
WO2022122132A1 (en) * 2020-12-09 2022-06-16 Symrise Ag Compositions comprising natural polymers and one or more (bio)-alkanediols
WO2022122139A1 (en) 2020-12-09 2022-06-16 Symrise Ag Process for the efficient preparation of (bio)-alkanediols
JP2023124497A (ja) * 2022-02-25 2023-09-06 花王株式会社 SARS-CoV-2不活化剤
KR102530593B1 (ko) * 2022-09-27 2023-05-10 한국콜마주식회사 방부 상승 효과를 갖는 방부시스템
WO2025088044A1 (en) * 2023-10-24 2025-05-01 Dsm Ip Assets B.V. Cosmetic composition comprising lacto-n-tetraose or lacto-n-neotetraose and a diol or triol or its ether or ester

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA995966A (en) * 1971-08-23 1976-08-31 Henry A. Dymsza Food preservation with glycols
US3836672A (en) * 1971-11-11 1974-09-17 J Frankenfeld Topical antifungal 1,3-diols
DE2204943A1 (de) 1972-02-03 1973-08-09 Exxon Research Engineering Co Keimtoetende reinigungsmittel und desinfektionsmittel
GB1604856A (en) * 1977-05-31 1981-12-16 Stafford Miller Ltd Use of certain polyol toxicants as ectoparasiticides or ovicides
US4863725A (en) 1982-10-27 1989-09-05 Deckner George E Novel clear oil-free moisturizer composition
US4507287A (en) * 1983-06-20 1985-03-26 Dixon Glen J Preparation and method for the treatment of acne
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US5041439A (en) * 1986-06-13 1991-08-20 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
EP0249397B1 (en) * 1986-06-13 1992-08-12 The Procter & Gamble Company Improved penetrating topical pharmaceutical compositions
EP0351897A3 (en) * 1988-06-17 1990-03-21 The Procter & Gamble Company Skin penetration system for salts of amine-functional drugs
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
SE464060B (sv) 1989-06-13 1991-03-04 Gunnar Swanbeck Anvaendning av pentandiol eller hexandiol foer framstaellning av ett medel foer behandling av infektioner orsakade av herpesvirus
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
ATE191844T1 (de) 1994-06-10 2000-05-15 Procter & Gamble Mundspülungsmittel
US5534243A (en) 1994-09-26 1996-07-09 The Procter & Gamble Company Aqueous oral compositions
SE9403541L (sv) * 1994-10-14 1996-04-15 Sven Moberg Antimikrobiell komposition
US6123953A (en) 1996-02-21 2000-09-26 Stoa S.A. Cosmetic, dermopharmaceutical or veterinary compositions for disinfecting human or animal skin
FR2785541B1 (fr) * 1998-11-09 2002-09-13 Oreal Systeme a activite antimicrobienne et son utilisation, notamment dans les domaines cosmetique et dermatologique
AU5460800A (en) 1999-06-02 2000-12-18 Aviana Biopharm Pharmaceutical transdermal compositions
BR9917389B1 (pt) 1999-06-25 2013-04-24 formulaÇÕes tàpicas compreendendo agentes de penetraÇço na pele e o uso das mesmas.
US7001603B2 (en) * 2001-02-28 2006-02-21 Color Access, Inc. Gelled two phase cosmetic compositions
SE0103528D0 (sv) * 2001-10-21 2001-10-21 Jan Faergeman Topiska kompositioner med förstärkt effekt
TWI220386B (en) * 2002-01-21 2004-08-21 Matsushita Electric Works Ltd Ultrasonic transdermal permeation device
DE10205190B4 (de) 2002-02-08 2017-06-08 Beiersdorf Ag 2-Methyl-1,3-propandiol haltige Zubereitungen
DE10206759A1 (de) * 2002-02-19 2003-08-28 Dragoco Gerberding Co Ag Synergistische Mischungen von 1,2-Alkandiolen
US20040047826A1 (en) * 2002-09-06 2004-03-11 Cosmetic Laboratories Of America, A Division Of St. Ives Laboratories, Inc. Fragrance formulation containing pearlescent silicone oil beads
SE0301862D0 (sv) 2003-06-26 2003-06-26 Jan Faergeman Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier

Also Published As

Publication number Publication date
CA2586815A1 (en) 2006-06-01
US9757596B2 (en) 2017-09-12
KR20070093079A (ko) 2007-09-17
AU2005310072A1 (en) 2006-06-01
RU2389481C2 (ru) 2010-05-20
EP1827433B2 (en) 2015-08-26
AU2005310072B2 (en) 2011-06-02
JP2008521799A (ja) 2008-06-26
RU2007124367A (ru) 2009-01-10
US20090221716A1 (en) 2009-09-03
WO2006057616A1 (en) 2006-06-01
EP1827433B1 (en) 2012-11-21
EP1827433A1 (en) 2007-09-05
JP5179879B2 (ja) 2013-04-10

Similar Documents

Publication Publication Date Title
AU2007230597B2 (en) Antimicrobial composition
BRPI0510599A (pt) compostos, processo para a preparação dos mesmos, composição farmacêutica, uso de um composto, e método para o tratamento e a profilaxia de doenças
BRPI0618374A2 (pt) uso de um composto ou um derivado do mesmo farmaceuticamente aceitável, métodos para matar microorganismos clinicamente latentes em um mamìfero, para tratar ou prevenir uma infecção microbiana em um mamìfero, para esterilizar um objeto, para preservar um material inorgánico ou orgánico, para tratar uma doença, para reduzir a dose de agente antimicrobiano convencional requerida para tratar uma infecção microbiana e para tratar uma doença de protozoário em um mamìfero, produto combinado, formulação, uso de um produto combinado, composto, e, processo para a preparação do mesmo
BRPI0514357A (pt) combinações para o tratamento de doenças que envolvem a proliferação de células
EP2305696A3 (en) Macrocyclic inhibitors of Hepatitis C virus replication
BRPI0514035A (pt) composto, sais farmaceuticamente aceitáveis do mesmo, diastereÈmeros, enanciÈmeros ou misturas do mesmo, uso de um composto, composição farmacêutica, método para a terapia de depressão em um animal de sangue quente, e, processo para preparar um composto
DE602005015833D1 (de) Imidazopyridin- und imidazopyrimidin-derivate als antibakterielle mittel
BRPI0508540A (pt) composto, composição farmacêutica, e, uso de um composto
CO5700767A2 (es) Procedimiento de tratamiento de rechazo de transplantes
NO20061657L (no) Pyrolderivater med antibakteriell aktivitet
BR0116216A (pt) Inibidores de girase e seus usos
BR0210791A (pt) Composição tendo atividade bacteristática e bactericida contra esporos bacterianos e células vegetativas e processo para tratamento de alimentos utilizando a mesma
BRPI0514032A (pt) composto, sais farmaceuticamente aceitáveis do mesmo, diastereÈmeros, enanciÈmeros ou misturas do mesmo, uso de um composto, composição farmacêutica, método para a terapia de depressão em um animal de sangue quente, e, processo para preparar um composto
UY31334A1 (es) 3a,4,5,6,7,7a-hexahidro-3h-benzoimidazol y derivaods de 3a, 4,5,6,,7,7a-hexahidro-3-indol, enantiómeros, diastereoisómeros, sales farmacéuticamente aceptadas, mezclas, composiciones, preparaciones y aplicaciones de las mismas
ATE441423T1 (de) Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen
WO2009043987A9 (fr) Compositions antibiotiques a base d'huiles essentielles - prophylaxie et traitement d'infections nosocomiales
NO20072089L (no) Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
CN109689061A (zh) 三唑并(4,5-d)嘧啶衍生物用于预防和治疗细菌感染的新用途
BRPI0519280A2 (pt) composto, composiÇço farmacÊutica e uso de um composto
BRPI0408150A (pt) composto, seu uso e processo para preparação do mesmo, métodos para tratamento ou profilaxia de cáncer e para produção de um efeito inibidor do ciclo celular (anti - proliferação celular) em um animal de sangue quente e composição farmacêutica
ATE528311T1 (de) Glycomimetische inhibitoren des pa-il-lectins, pa-iil-lectins oder beider lectine aus pseudomonas
DE602006018893D1 (de) Anwendung von levo-ornidazol bei der herstellung eines medikaments gegen infektion mit anaeroben bakterien
BRPI0413413A (pt) feniloxazolidinonas de piperidino substituìdo tendo atividade antimicrobiana com eficácia in vivo melhorada
CA2529441A1 (en) Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas
BR0314261A (pt) Compostos, processo de preparação de um composto, composição farmacêutica que compreende o mesmo, utilização de um composto, método para tratamento e/ou profilaxia de enfermidades e utilização e/ou método de tratamento

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.